Tocilizumab in Amyloidosis-Associated Kidney Disease Secondary to Inflammatory Bowel Diseases

被引：0
作者：
A. Cañas-Ventura
E. Rodríguez
M. Andreu
L. Márquez
机构：
[1] Pompeu Fabra University,Gastroenterology Department, Hospital del Mar, Research Institute of Hospital del Mar
[2] Pompeu Fabra University,Nephrology Department, Hospital del Mar, Research Institute of Hospital del Mar
来源：
Digestive Diseases and Sciences | 2013年 / 58卷
关键词：
Inflammatory Bowel Disease; Infliximab; Amyloidosis; Adalimumab; Tocilizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2736 / 2737
页数：1
相关论文
共 12 条
  • [1] Hattori Y(2012)Tocilizumab improves cardiac disease in a hemodialysis patient with AA amyloidosis secondary to rheumatoid arthritis Amyloid 19 37-40
  • [2] Ubara Y(2010)Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis Clin Rheumatol 29 1195-1197
  • [3] Sumida K(2011)Successful use of tocilizumab in a patient with nephrotic syndrome due to a rapidly progressing AA amyloidosis secondary to latent tuberculosis Amyloid 18 235-239
  • [4] Hiramatsu R(undefined)undefined undefined undefined undefined-undefined
  • [5] Inoue D(undefined)undefined undefined undefined undefined-undefined
  • [6] Arima H(undefined)undefined undefined undefined undefined-undefined
  • [7] Kawanami C(undefined)undefined undefined undefined undefined-undefined
  • [8] Takiuchi Y(undefined)undefined undefined undefined undefined-undefined
  • [9] Magro-Checa C(undefined)undefined undefined undefined undefined-undefined
  • [10] Navas-Parejo Casado A(undefined)undefined undefined undefined undefined-undefined
12